OVCA2 anticorps (AA 11-100) (Cy3)

N° du produit ABIN717074

Détail du produit anti-OVCA2 anticorps (Cy3)

Antigène: OVCA2 (Ovarian Tumor Suppressor Candidate 2 (OVCA2))

Épitope: AA 11-100

Reactivité: Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp OVCA2 est conjugé à/à la Cy3

Application: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Rat

Homologie: Human,Mouse,Dog,Cow,Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human OVCA2

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur OVCA2

Antigène: OVCA2 (Ovarian Tumor Suppressor Candidate 2 (OVCA2))

Autre désignation: OVCA2 (OVCA2 Produits)

Synonymes: anticorps 9030414M07Rik, anticorps RGD1564623, anticorps zgc:110011, anticorps OVCA2, serine hydrolase domain containing, anticorps candidate tumor suppressor in ovarian cancer 2, anticorps OVCA2 serine hydrolase domain containing, anticorps OVCA2, anticorps Ovca2, anticorps ovca2

Sujet:

Synonyms: Candidate tumor suppressor in ovarian cancer 2, Candidate tumor suppressor OVCA2, ovarian cancer associated gene 2 protein, Ovarian cancer gene 2 protein, ovarian tumor suppressor candidate 2, OVCA2_HUMAN.

Background: Ubiquitously expressed protein which belongs to the UPF0483 (OVCA2) family. Encoded in an intron of the gene DPH1/OVCA1 (same strand).